HPV E7 protein detection kit (immunocytochemical method)

In vitro qualitative detection kit for 15 high-risk HPV E6/E7 mRNA subtypes in cervical exfoliated cell samples. Detects HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68 for cervical cancer and precancerous lesion risk assessment. NMPA Class III medical device registered.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.

Molecular assay for identifying 14 WHO-defined high-risk HPV types and 4 additional clinically relevant HPV types associated with cervical cancer. Enables comprehensive cervical cancer risk stratification.

HPV 15 genotype detection kit using fluorescence PCR melting curve analysis for identifying human papillomavirus types in clinical specimens. Enables rapid, simultaneous detection and differentiation of multiple HPV genotypes relevant to cervical cancer screening and risk stratification.

A fluorescent PCR melting curve method-based detection kit for genotyping Human Papillomavirus through E6/E7 mRNA analysis. This kit enables molecular diagnostics of HPV infections at the mRNA level.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

A diagnostic test kit detecting 18 types of human papillomavirus including 14 high-risk types recognized by WHO as causative agents of cervical cancer and 4 medium-risk types associated with cervical cancer, using hybrid capture-chemiluminescence method.

Test for detection of human papillomavirus E7 oncoprotein from HPV types 16 and 18. Assists in cervical cancer risk assessment and screening.

An HPV E6/E7 mRNA genotyping detection assay that provides risk stratification for cervical lesions. It reduces unnecessary colposcopy referrals while improving the detection rate of CIN2+ lesions and enabling more precise clinical management.

A fluorescent PCR melting curve method-based detection kit for identifying Human Papillomavirus (HPV) 31 genotypes. This diagnostic kit is designed for molecular diagnostics applications and enables precise genotyping of HPV infections.

Multiplex real-time PCR kit for simultaneous detection and genotyping of human papillomavirus (HPV) E6/E7 mRNA targets. Enables identification of multiple HPV genotypes in a single reaction, supporting cervical cancer screening and risk stratification in clinical laboratories.

Real-time PCR kit for detection and genotyping of HPV E6/E7 mRNA in clinical specimens. Enables rapid identification of high-risk HPV types through multiplex amplification technology, supporting cervical cancer screening and risk stratification in molecular diagnostics laboratories.